Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Hussain, Akthar ^a   Moodley, Dhayendre ^a   Naidoo, Sudhindra ^a   Esterhuizen, Tonya M ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS SECTIONAL STUDY; FEMALE; GESTATIONAL AGE; HEALTH CARE ACCESS; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN MORBIDITY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; RISK FACTOR; SINGLE DRUG DOSE; SOUTH AFRICA; STILLBIRTH; STUDY DESIGN; VERTICAL TRANSMISSION; ADOLESCENT; CD4+ T LYMPHOCYTE; CHILD; CROSS-SECTIONAL STUDY; CYTOLOGY; HEALTH CARE DELIVERY; MIDDLE AGED; PREGNANCY COMPLICATION; PREVALENCE; WOMEN'S HEALTH;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE; SOUTH AFRICA; WOMEN'S HEALTH;

EID: 82655180442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027907     Document Type: Article

References (24)

1. Joint United Nations Program on HIV/AIDS (UNAIDS), World Health Organization (WHO) (2010) Report on the global AIDS epidemic.
2. Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, et al. (2007) Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis 196 (3): S474-81.
3. National Department of Health (2008) Policy and Guidelines for the Implementation of the PMTCT Program South Africa.
4. Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, et al. (2010) Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women's health services. Trop Med Int Health [Epub ahead of print].
5. Tsague L, Tsiouris FO, Carter RJ, Mugisha V, Tene G, et al. (2010) Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens. BMC Public Health 10: 753.
6. National Department of Health (2010) Policy and Guidelines for the Implementation of the PMTCT Program South Africa.
7. World Health Organisation (2009) Rapid advice: use of antiretroviral drugs for treating pregnant women and prevnting HIV infection in infants Geneva WHO.
8. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, et al. (2010) Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission. AIDS 24 (9): 1374-7.
9. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. (2010) Antiretroviral Regimens in Pregnancy and Breastfeeding in Botswana. N Engl J Med 362 (24): 2282-94.
10. The Kesho Bora Study Group (2011) Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora Study): a randomized controlled trial. Lancet Infect Dis 11: 171-80.
11. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, et al. (2010) for the BAN Study Group. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362 (24): 2271-81.
12. Kalish LA, Pitt J, Lew J, Landesman S, Diaz C, et al. (1997) Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS). J Infect Dis 175: 712-715.
13. Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, et al. (2011) Association of recent HIV infection and in utero HIV-1 transmission: Findings from the PEPI-Malawi trial. AIDS. [Epub ahead of print].
14. Saving Mothers 2005-2007: Fourth Report on Confidential Enquiries into Maternal Deaths in SA. NCCEMD [National Committee for the Confidential Enquiries into Maternal Deaths].
15. Thorne C, Patel D, Newell ML, (2004) Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 18 (17): 2337-9.
16. Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, et al. (2005) Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 38 (4): 449-73.
17. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ, (2006) Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 193 (9): 1195-201.
18. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, et al. (2010) Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis 201 (7): 1035-44.
19. van der Merwe K, Hoffman R, Black V, Chersich M, Coovadia A, et al. (2011) Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc 14: 42-53.
20. Townsend C, Schulte J, Thorne C, Dominquez KI, Tookey PA, et al. (2010) Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 117 (11): 1399-410.
21. Nakakeeto ON, Kumaranayake L, (2009) The global strategy to eliminate HIV infection in infants and young children: a seven-country assessment of costs and feasibility. AIDS 23: 987-995.
22. Sprague C, Chersich MF, Black V, (2011) Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: a qualitative enquiry. AIDS Res Ther 8 (10).
23. Carter RJ, Dugan K, El-Sadr W, Myer L, Otieno J, et al. (2010) CD4 cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource limited settings. J Acquir Immune Defic Syndr.
24. Zolfo M, De Weggheleire A, Schouten E, Lynen L, (2010) Time for "Test and Treat" in Prevention of Mother-to-Child Transmission Programs in Low-and Middle-Income Countries. J AIDS 55: 287-289.